pharma · Critical Limb Ischemia (CLI) · Sarcoma · DSGN
Lxo Ireland Designated
Lxo Ireland Designated Activity Company
Lxo Ireland Designated clinical programs — 68 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- CARLSBAD, CA, IE
- Programs
- 68
- Drugs
- 61
- Patents
- 201
Lxo Ireland Designated projects
68 ClinicalTrials.gov programs sponsored by Lxo Ireland Designated.
Lxo Ireland Designated has 68 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Allo-depleted lymphocyte infusion
Lxo Ireland Designated Activity Company
Transplant-Related Hematologic Malignancy
1 trial -
CEA protein antigen plus BCG Vaccine Mix for percutaneous use
Lxo Ireland Designated Activity Company
Rectal Cancer
1 trial -
Carfilzomib
Lxo Ireland Designated Activity Company
Acute Lymphoblastic Leukemia (ALL)
1 trial -
DT-216
Lxo Ireland Designated Activity Company
Friedreich Ataxia
2 trials -
GLA-AF
Lxo Ireland Designated Activity Company
Healthy Volunteers
1 trial -
GLA-SE
Lxo Ireland Designated Activity Company
Merkel Cell Carcinoma
1 trial -
HSV 2 Formulation 1
Lxo Ireland Designated Activity Company
Genital Herpes
1 trial -
ID-LV305
Lxo Ireland Designated Activity Company
Melanoma - Currently Enrolling
1 trial -
IDC-G305
Lxo Ireland Designated Activity Company
Melanoma
1 trial -
IND 179135 Research
Lxo Ireland Designated Activity Company
HIV Infections
1 trial -
IND165646
Lxo Ireland Designated Activity Company
Covid19
1 trial -
Infudopa i.v.
Lxo Ireland Designated Activity Company
Parkinson Disease
1 trial -
MSD-001
Lxo Ireland Designated Activity Company
Mental Health Disorders
1 trial -
Novel restraint
Lxo Ireland Designated Activity Company
Acute Respiratory Failure
1 trial -
Switch active lifestyles brought to you by MediaWise
Lxo Ireland Designated Activity Company
Overweight
1 trial -
Hyperbaric bupivacaine+Sufentanil
Lxo Ireland Designated Activity Company
Anesthesia; Functional
1 trial -
Low intensity laser for oral mucositis
Lxo Ireland Designated Activity Company
Oral Mucositis
1 trial -
Pre-dilation side branch
Lxo Ireland Designated Activity Company
Coronary Angiography
1 trial -
Roflumilast alternated days
Lxo Ireland Designated Activity Company
Chronic Obstructive Pulmonary Disease (COPD)
1 trial -
Subcutaneous glargine insulin
Lxo Ireland Designated Activity Company
Diabetes Mellitus
1 trial
Frequently asked questions
How many clinical projects does Lxo Ireland Designated have?
68 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.